A pair of teams vying to put a stamp on overachieving campaigns will meet as Georgia Tech squares off with Vanderbilt in the Birmingham Bowl on Friday in Birmingham, Ala. Georgia Tech (7-5) is appearing in back-to-back bowl games for the first time since an 18-year run from 1997-2014, and a win would give the Yellow Jackets consecutive bowl wins for the first time in 20 years. For a Georgia Tech program that endured a 14-32 stretch from 2019-22, this season has given Yellow Jacket fans a reason to believe a resurgence is near. After knocking off No. 10 Florida State in the season opener, Georgia Tech climbed into the AP Poll for the first time in nine years. Although it was a short stay in the rankings, head coach Brent Key's team piqued the nation's interest again in November, when it took down undefeated No. 4 Miami, 28-23. The Yellow Jackets had another chance to shake up the college football landscape against then-No. 7 Georgia, but blew a late 14-point lead en route to an eight-overtime defeat. Now with one more opportunity against the Southeastern Conference, Key thinks the bowl organizers nailed this one on the head. "We're excited to go over to Birmingham and play a really good opponent," Key said. "I think this is a really good matchup. When you look at bowl games, that's what you look for, the matchups. And I think they got this one right." Georgia Tech quarterback Haynes King's 1,910 passing yards and 22 total touchdowns (11 passing, 11 rushing) have steadied the offense throughout the year, but the Yellow Jackets will be without their leading receiver, Eric Singleton Jr., who entered the transfer portal after the regular season and signed with Auburn on Monday. Starting defensive lineman Romello Height also transferred, meaning a next-man-up mentality will be in order for Key's squad. "One person is not going to make a difference as far as rotational depth," Key said. "We're going to continue to coach the guys that are here, and prepare them not only for this game but for the rest of their careers here at Georgia Tech." Singleton paced Georgia Tech with 754 receiving yards to go along with four total touchdowns, while Height tallied 2 1/2 sacks and a pair of forced fumbles. It wouldn't have surprised many college football pundits had Vanderbilt missed the postseason for a sixth straight year. The Commodores (6-6) were predicted last by a wide margin in the SEC preseason poll coming off last year's winless conference slate. However, the program's historic season can now be punctuated with its first bowl win in 11 years, thanks to a shocking Oct. 5 victory over No. 1 Alabama, along with its first win all-time at Auburn. Led by head coach Clark Lea, the revamped Commodores see a similar program on Friday in Birmingham. "Georgia Tech is a team I've taken notes on as Brent has built that program up," Lea said. "What an incredible transformation they've had; so much respect for them. ... This is our 10th bowl game in 134 years, it's a chance for our first winning season since 2013. You're going to have two teams that play a physical brand of football, two head coaches that care deeply about the institutions we represent. "These are two teams that are going to fight for a win and I don't think it gets better than that." The Commodores are led by quarterback Diego Pavia, who had 2,133 passing yards and 17 touchdowns in the air, paired with 716 rushing yards and six scores on the ground. Pavia, a transfer from New Mexico State -- and New Mexico Military Institute at the juco level -- won a court ruling last week that granted him a seventh year of eligibility in 2025. --Field Level MediaBURLINGTON, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. NEUP (" Neuphoria " or the " Company ") is pleased to announce that its previously announced scheme of arrangement in relation to Bionomics Limited's proposed re-domiciliation from Australia to the United States, under which Neuphoria will become the ultimate parent company of Bionomics Limited, has been implemented today, December 23, 2024 New York time (December 24, 2024 Sydney time). The shares of common stock of Neuphoria (" Neuphoria Shares ") issued today in connection with the re-domiciliation are expected to commence trading on The Nasdaq Stock Market LLC under the symbol "NEUP" on December 24, 2024 or as soon as possible thereafter. In addition, Neuphoria will issue options to acquire shares of common stock in Neuphoria (" Neuphoria Options ") to holders of options to acquire shares in Bionomics (" Bionomics Options ") that were issued by Bionomics, in exchange for their Bionomics Options. Neuphoria will also issue a warrant to purchase 1,054,381 shares of common stock in Neuphoria (" Neuphoria Warrant ") to an institutional investor that holds a warrant to purchase 12,652,572 American Depositary Shares ("ADSs") of Bionomics (" Bionomics Warrant "), in exchange for the Bionomics Warrant. Further details regarding the implementation of the redomiciliation can be found in a Current Report on Form 8-K that will be filed by Neuphoria with the SEC. For further information, please contact: General Investor Relations Investor Relations Spyridon (Spyros) Papapetrolpoulos Kevin Gardner Chris Calabrese info@neuphoriatx.com kgardner@lifesciadvisors.com ccalabrese@lifesciadvisors.com About Neuphoria Therapeutics Inc. Neuphoria NEUP is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. Neuphoria is advancing its lead drug candidate, BNC210, an oral, proprietary, selective negative allosteric modulator of the α7 nicotinic acetylcholine receptor, for the acute, "as needed" treatment of social anxiety disorder (SAD) and for chronic treatment of post-traumatic stress disorder (PTSD). BNC210 is a first-of-its-kind, well-tolerated, broad spectrum anti-anxiety experimental therapeutic, designed to restore neurotransmitter balance in relevant brain areas, providing rapid relief from stress and anxiety symptoms without the common pitfalls of sedation, cognitive impairment, or addiction. In addition, Neuphoria has a strategic partnership with Merck & Co., Inc. (known as MSD outside the United States and Canada) with two drugs in early-stage clinical trials for the treatment of cognitive deficits in Alzheimer's disease and other central nervous system conditions. Neuphoria's pipeline also includes the α7 nicotinic acetylcholine receptor next generation and the Kv3.1/3.2 preclinical programs, both in the lead optimization development stage. Forward-Looking Statements Neuphoria cautions that statements included in this press release that are not a description of historical facts are forward-looking statements. Words such as "may," "could," "will," "would," "should," "expect," "plan," "anticipate," "believe," "estimate," "intend," "predict," "seek," "contemplate," "potential," "continue" or "project" or the negative of these terms or other comparable terminology are intended to identify forward-looking statements. The forward-looking statements are based on our current beliefs and expectations. The inclusion of forward-looking statements should not be regarded as a representation by Neuphoria that any of its plans will be achieved. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business and other risks described in the Company's filings with the SEC, including the Company's Annual Report on Form 10-K filed with the SEC, and its other reports. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Neuphoria undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. Further information regarding these and other risks, uncertainties and other factors is included in Neuphoria's filings with the SEC, copies of which are available from the SEC's website ( www.sec.gov ) and on Neuphoria's website ( www.neuphoriatx.com ) under the heading "Investor Center." All forward-looking statements are qualified in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995. Neuphoria expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Not an offer of securities This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any securities in any jurisdiction. The Neuphoria Shares, Neuphoria Options and Neuphoria Warrant have not been registered under the US Securities Act and may not be offered or sold except in a transaction registered under the US Securities Act or in a transaction exempt from such registration requirements and applicable US state securities laws. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.Syrian rebels topple Assad, transforming nation and Middle East
Stock market today: Wall Street rises at the start of a holiday-shortened weekAs the Christmas season unfolds, BTS' V, also known as Kim Taehyung, is once again enchanting the ARMY with his soulful voice, continuing his yearly tradition. This time, he has joined forces with the legendary jazz musician Bing Crosby for a posthumous rendition of the iconic holiday classic White Christmas. This collaboration not only brings a fresh and heartfelt twist to the beloved song but also serves as a touching tribute to Taehyung’s late dog, Yeontan, making it a deeply personal and emotional gift to his fans during this festive time. BTS' V Pays Tribute To Late Dog Yeontan In White Christmas On Friday, December 6, the official social media handle released the much-anticipated music video for the collaboration between BTS’ V and the legendary Bing Crosby, reviving one of the best-selling singles of all time. This partnership brings together two global icons: V, a pop sensation of the 21st century, and Crosby, whose legacy in music is unparalleled. The song’s lyrics capture the holiday season's magic with themes of love and warmth. The animated music video features Bing Crosby delivering gifts on Santa’s sleigh, with V’s late dog Yeontan by his side, adding a heartfelt tribute and a touch of holiday joy. The release is especially significant as it marks 47 years since Crosby's iconic holiday duet with David Bowie in 1977, adding an extra layer of nostalgia and excitement for fans. V expressed his heartfelt gratitude for being part of such a special collaboration, sharing his deep appreciation for Bing Crosby’s legendary work. In an official statement, the BTS member said, "I’m truly thankful for the opportunity to be featured in a song with my all-time favourite jazz artist, Bing Crosby.” “Growing up, I listened to his song 'It’s Been a Long, Long Time' countless times each day, so it feels surreal to have the chance to sing alongside someone whose voice I have admired for so long. To collaborate with the voice of an idol I’ve looked up to for years is an incredible honor. As a huge fan of his, I made sure to sing with the utmost sincerity and respect,” Kim Taehyung further added.Jordan Sears scores 25 points, Jalen Reed has double-double and LSU outlasts UCF 109-102 in 3OT
Out There: Spirit of Christmas lives in our hearts and in our apps
Winston's performance in snowy win over Steelers adds new layer to Browns' quarterback conundrumJets deliver payback to Leafs, claim NHL's top spot before Christmas break